The DOI matches its Crossref record; 26 of the 26 references it cites were found in a registry or an index.
Enhancement of tumor necrosis factor α antitumor immunotherapeutic properties by targeted delivery to aminopeptidase N (CD13)
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
An endotoxin-induced serum factor that causes necrosis of tumors
Carswell, E. A., Old, L. J., Kassel, R. L., Green, S., Fiore, N., & Williamson, B. (1975) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.72.9.3666 · Cited by 4,532
Cancer Treatment by Targeted Drug Delivery to Tumor Vasculature in a Mouse Model
Arap, W., Pasqualini, R., & Ruoslahti, E. (1998) · Science · doi:10.1126/science.279.5349.377 · Cited by 2,054
Modulation of endothelial cell hemostatic properties by tumor necrosis factor.
Nawroth, P. P., & Stern, D. M. (1986) · The Journal of experimental medicine · doi:10.1084/jem.163.3.740 · Cited by 1,311
Aminopeptidase N is a receptor for tumor-homing peptides and a target for inhibiting angiogenesis.
Pasqualini, R., Koivunen, E., Kain, R., Lahdenranta, J., Sakamoto, M., Stryhn, A., Ashmun, R., Shapiro, L., Arap, W., & Ruoslahti, E. I. (2000) · PubMed · Cited by 859
αv Integrins as receptors for tumor targeting by circulating ligands
Pasqualini, R., Koivunen, E., & Ruoslahti, E. (1997) · Nature Biotechnology · doi:10.1038/nbt0697-542 · Cited by 744
Ljunggren, H. G., & Kärre, K. (1985) · The Journal of experimental medicine · doi:10.1084/jem.162.6.1745 · Cited by 736
Lienard, D., Ewalenko, P., Delmotte, J. J., Renard, N., & Lejeune, F. J. (1992) · Journal of Clinical Oncology · doi:10.1200/jco.1992.10.1.52 · Cited by 719
Tumor targeting with a selective gelatinase inhibitor
Koivunen, E., Arap, W., Valtanen, H., Rainisalo, A., Medina, O. P., Heikkilä, P., Kantor, C., Gahmberg, C. G., Salo, T., Konttinen, Y. T., et al. (1999) · Nature Biotechnology · doi:10.1038/11703 · Cited by 567
Aminopeptidases: structure and function
Taylor, A. (1993) · The FASEB Journal · doi:10.1096/fasebj.7.2.8440407 · Cited by 554
Eggermont, A. M. M., Koops, H. S., Klausner, J. M., Kroon, B. B. R., Schlag, P. M., Liénard, D., van Geel, A. N., Hoekstra, H. J., Meller, I., Nieweg, O. E., et al. (1996) · Annals of Surgery · doi:10.1097/00000658-199612000-00011 · Cited by 460
The active form of tumor necrosis factor is a trimer.
Smith, R. A., & Baglioni, C. (1987) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)48183-5 · Cited by 429
Eggermont, A. M., Schraffordt Koops, H., Liénard, D., Kroon, B. B., van Geel, A. N., Hoekstra, H. J., & Lejeune, F. J. (1996) · Journal of Clinical Oncology · doi:10.1200/jco.1996.14.10.2653 · Cited by 398
Cloning and expression in Escherichia coli of the cDNA for murine tumor necrosis factor.
Pennica, D., Hayflick, J. S., Bringman, T. S., Palladino, M. A., & Goeddel, D. V. (1985) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.82.18.6060 · Cited by 390
Hematopoietic differentiation antigens that are membrane-associated enzymes: cutting is the key!
Shipp, M., & Look, A. (1993) · Blood · doi:10.1182/blood.v82.4.1052.1052 · Cited by 384
Asher, A. L., Mulé, J. J., Kasid, A., Restifo, N. P., Salo, J. C., Reichert, C. M., Jaffe, G., Fendly, B., Kriegler, M., & Rosenberg, S. A. (1991) · The Journal of Immunology · doi:10.4049/jimmunol.146.9.3227 · Cited by 281
Tumor necrosis factor enhances HLA-A,B,C and HLA-DR gene expression in human tumor cells.
Pfizenmaier, K., Scheurich, P., Schlüter, C., & Krönke, M. (1987) · The Journal of Immunology · doi:10.4049/jimmunol.138.3.975 · Cited by 244
Fraker, D. L., Alexander, H. R., Andrich, M., & Rosenberg, S. A. (1996) · Journal of Clinical Oncology · doi:10.1200/jco.1996.14.2.479 · Cited by 213
Palladino, M. A., Shalaby, M. R., Kramer, S. M., Ferraiolo, B. L., Baughman, R. A., Deleo, A. B., Crase, D., Marafino, B., Aggarwal, B. B., Figari, I. S., et al. (1987) · The Journal of Immunology · doi:10.4049/jimmunol.138.11.4023 · Cited by 201
Tumor necrosis factor/cachectin-induced intravascular fibrin formation in meth A fibrosarcomas.
Nawroth, P., Handley, D., Matsueda, G., De Waal, R., Gerlach, H., Blohm, D., & Stern, D. (1988) · The Journal of experimental medicine · doi:10.1084/jem.168.2.637 · Cited by 162
Talmadge, J. E., Tribble, H. R., Pennington, R., Phillips, H., & Wiltrout, R. H. (1987) · PubMed · Cited by 134
Líénard, D., Lejeune, F. J., & Ewalenko, P. (1992) · World Journal of Surgery · doi:10.1007/bf02071526 · Cited by 122
Chromogranin A Fragments Modulate Cell Adhesion
Gasparri, A. M., Sidoli, A., Sánchez, L. P., Longhi, R., Siccardi, A. G., Marchisio, P. C., & Corti, A. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.33.20835 · Cited by 76
Self-citationTumor cell targeting with antibody-avidin complexes and biotinylated tumor necrosis factor alpha.
Moro, M., Pelagi, M., Fulci, G., Paganelli, G., Dellabona, P., Casorati, G., Siccardi, A. G., & Corti, A. (1997) · PubMed · Cited by 73
Self-citationHansen, A. S., Norén, O., Sjöström, H., & Werdelin, O. (1993) · European Journal of Immunology · doi:10.1002/eji.1830230946 · Cited by 61
Gasparri, A. M., Moro, M., Curnis, F., Sacchi, A., Pagano, S., Veglia, F., Casorati, G., Siccardi, A. G., Dellabona, P., & Corti, A. (1999) · PubMed · Cited by 56
Self-citationDemonstration of immunogenicity with the poorly immunogenic B16 melanoma.
Celik, C., Lewis, D. A., & Goldrosen, M. H. (1983) · PubMed · Cited by 28
Cited by
Specialization of tumour vasculature
Ruoslahti, E. (2002) · Nature Reviews Cancer · doi:10.1038/nrc724 · Cited by 722
Gelatinase-mediated migration and invasion of cancer cells
Björklund, M., & Koivunen, E. (2005) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2005.03.001 · Cited by 661
Steps toward mapping the human vasculature by phage display
Arap, W., Kolonin, M. G., Trepel, M., Lahdenranta, J., Cardó-Vila, M., Giordano, R. J., Mintz, P. J., Ardelt, P. U., Yao, V. J., Vidal, C. I., et al. (2002) · Nature Medicine · doi:10.1038/nm0202-121 · Cited by 607
Srinivasarao, M., & Low, P. S. (2017) · Chemical Reviews · doi:10.1021/acs.chemrev.7b00013 · Cited by 605
Neri, D., & Bicknell, R. (2005) · Nature Reviews Cancer · doi:10.1038/nrc1627 · Cited by 600
Metadata
- Authors
- Curnis, F., Sacchi, A., Borgna, L., Magni, F., Gasparri, A., & Corti, A.
- Venue
- Nature Biotechnology
- Published
- 2000-11
- Volume
- 18
- Issue
- 11
- Pages
- 1185-1190
- ISSN
- 0733-222X (ISSN-L)
- 1087-0156
- 1546-1696
- OpenAlex
- W1559937222
- Cited by
- 419
- References
- 26
- FWCI
- 3.94
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.